Literature DB >> 7981753

A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3.

H Watkins1, C MacRae, L Thierfelder, Y H Chou, M Frenneaux, W McKenna, J G Seidman, C E Seidman.   

Abstract

Familial hypertrophic cardiomyopathy (FHC) is caused by missense mutations in the beta cardiac myosin heavy chain (MHC) gene in less than half of affected individuals. To identify the location of another gene involved in this disorder, a large family with FHC not linked to the beta MHC gene was studied. Linkage was detected between the disease in this family and a locus on chromosome 1q3 (maximum multipoint lod score = 8.47). Analyses in other families with FHC not linked to the beta MHC gene, revealed linkage to the chromosome 1 locus in two and excluded linkage in six. Thus mutations in at least three genetic loci can cause FHC. Three sarcomeric contractile proteins--troponin I, tropomyosin and actin--are strong candidate FHC genes at the chromosome 1 locus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7981753     DOI: 10.1038/ng0493-333

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  33 in total

1.  Malignant familial hypertrophic cardiomyopathy in a family with a 453Arg-->Cys mutation in the beta-myosin heavy chain gene: coexistence of sudden death and end-stage heart failure.

Authors:  Y L Ko; J J Chen; T K Tang; J J Cheng; S Y Lin; Y C Liou; P Kuan; C W Wu; W P Lien; C C Liew
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

2.  Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication.

Authors:  H Fujita; S Sugiura; S Momomura; M Omata; H Sugi; K Sutoh
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

Review 3.  [Genetic causes of hypertrophic cardiomyopathy].

Authors:  H P Vosberg
Journal:  Med Klin (Munich)       Date:  1998-04-15

4.  Clinical implications of hypertrophic cardiomyopathy associated with mutations in the alpha-tropomyosin gene.

Authors:  K Yamauchi-Takihara; C Nakajima-Taniguchi; H Matsui; Y Fujio; K Kunisada; S Nagata; T Kishimoto
Journal:  Heart       Date:  1996-07       Impact factor: 5.994

5.  Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein.

Authors:  W Rottbauer; M Gautel; J Zehelein; S Labeit; W M Franz; C Fischer; B Vollrath; G Mall; R Dietz; W Kübler; H A Katus
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

6.  Hypertrophic cardiomyopathy.

Authors:  M Burch
Journal:  Arch Dis Child       Date:  1994-12       Impact factor: 3.791

7.  The devil's in the details: progress in familial hypertrophic cardiomyopathy.

Authors:  M Keating
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

8.  Familial hypertrophic cardiomyopathy. Microsatellite haplotyping and identification of a hot spot for mutations in the beta-myosin heavy chain gene.

Authors:  E Dausse; M Komajda; L Fetler; O Dubourg; C Dufour; L Carrier; C Wisnewsky; J Bercovici; C Hengstenberg; S al-Mahdawi
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 9.  Molecular basis of hypertrophic and dilated cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  Tex Heart Inst J       Date:  1994

10.  Mapping the locus for familial hypertrophic cardiomyopathy to chromosome 11 in a family with a case of apical hypertrophic cardiomyopathy of the Japanese type.

Authors:  Y L Ko; J J Chen; T K Tang; M S Teng; S Y Lin; P Kuan; C W Wu; W P Lien; C C Liew
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.